<html>
<head>
<title>Federal Register, Volume 90 Issue 228 (Monday, December 1, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 228 (Monday, December 1, 2025)]
[Notices]
[Page 55135]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-21661]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR Panel: Cancer Biomarker Research (R21).
    Date: January 30, 2026.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Robert F. Gahl, Ph.D., Scientific Review 
Officer, Cancer Diagnosis, Prevention and Therapeutics, Division of 
Translational and Clinical Sciences, Center for Scientific Review, 
National Cancer Institute, Rockville, MD 20850, (240) 276-7869, 
<a href="/cdn-cgi/l/email-protection#e6948984839492c881878e8aa6888f8ec8818990"><span class="__cf_email__" data-cfemail="7c0e131e190e08521b1d14103c121514521b130a">[email&#160;protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: November 25, 2025.
Sterlyn H. Gibson,
Program Specialist, Office of Federal Advisory Committee Policy.
[FR Doc. 2025-21661 Filed 11-28-25; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>